This announcement is a separate document:
あすか製薬ホールディングス：経口避妊薬ドロスピレノン（Drospirenone）の韓国における製造販売承認取得のお知らせ
ASKA Pharmaceutical Holdings: Announcements of individual stocks: Approval has been obtained for the manufacture and sale of the oral contraceptive drospirenone in South Korea.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.